Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4525-4530

  Skinner, Margot A ^a   Yuan, Shining ^a   Prestidge, Ross ^a   Chuk, David ^a   Watson, James D ^a   Tan, Paul L J ^a  

^a Genesis Research & Development Corporation Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MYCOBACTERIUM VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HELPER CELL; IMMUNIZATION; MACROPHAGE; MEMORY CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUBERCULOSIS;

EID: 0030862227     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4525-4530.1997     Document Type: Article

References (26)

1. Abou-Zeid, C., M.-P. Gares, J. Inwald, R. Janssen, Y. Zhang, D. B. Young, C. Hetzel, J. R. Lamb, S. L. Baldwin, I. M. Orme, V. Yeremeev, B. V. Nikonenko, and A. S. Apt. 1997. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect. Immun. 65:1856-1862.
2. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995 Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
3. Bloom, B. R., and C. J. L. Murray. 1992 Tuberculosis: commentary on a re-emergent killer. Science 257:1055-1064.
4. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of Tuberculosis. JAMA 271:698-702.
5. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene disrupted mice. J. Exp. Med. 178:2243-2247.
6. Cooper, A. M., C. D'Souza, A. A. Frank, and I. M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1317-1320.
7. Dannenberg, A. M., Jr., and G. A. W. Rook. 1994. Pathogcnesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses-dual mechanisms that control bacillary multiplication, p. 459-483. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
8. DeLibero, G., I. Flesch, and S. H. E. Kaufmann. 1988. Mycobacteria reactive Lyt2+ T cell lines. Eur. J. Immunol. 18:59-66.
9. Etemadi, A., R. Farid, and J. L. Stanford. 1992. Immunotherapy for multi-drug-resistant tuberculosis. Lancet 340:1360-1361.
10. Flesch, I. E. A., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. E. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumour necrosis factor α. J. Exp. Med. 181:1615-1621.
11. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatihility complex class 1-restrictcd T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
12. Laochumroonvorapong, P., J. Wang, C. C. Liu, W. Ye, A. L. Moreira, K. B. Elkon, V. H. Freedman, and G. Kaplan. 1997. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of myco-bacterial infection in mice. Infect. Immun. 65:127-132.
13. Muller, I., S. P. Cobbold, H. Waldmann, and S. H. E. Kaufmann. 1987. Impaired resistance against Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt2+ T cells. Infect. Immun. 55:2037-2041.
14. Onyebujoh, P. C., T. Abdulmumini, S. Robinson, G. A. W. Rook, and J. L. Stanford. 1995. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. Respir. Med. 89:199-207.
15. Orme, I. M. 1987. The kinetics and emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacteriun tuberculosis. J. Immunol. 138:293-298.
16. Orme, I. M. 1988. Induction of nonspecific acquired resistance and dclayed-type hypersensitivity but nol specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310-3312.
17. Orme, I. M., E. S. Miller. A. D. Roberts, S. K. Furney, J. P. Griffin. K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mvcobacterium tuber culosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189-196.
18. Orme, L. M., and F. M. Cullins. 1994. Mouse model of tuberculosis, p. 113-134. In B. R. Bloom (ed.). Tuberculosis: pathogcnesis. protection, and control. ASM Press. Washington. DC.
19. Ottenhoff, T. H. M., A. B. Kale. J. D. A. Van Embden. J. E. K. Thole, and R. Kiessling. 1988. The recomhinant 65 kD heat shock protein of Mycobacterium bovis BCG/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes. J. Exp. Med. 168:1997-1992.
20. Sad, S., R. Marcotte, and T. R. Mossman. 1995. Cytokme-induced differentiation of precursor mouse CD8+ T cells into cytoloxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2:27l-279.
21. Silva, C. L., M. K. Silva, R. C. L. R. Pietro, and D. B. Lowrie. 1996. Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination wilh tumor cells expressing mycohacterial hsp65. Infccl. Immun. 64:2400-2407.
22. Stanford. J. L.. P. C. Onycbujoh, R. A. W. Rook, J. M. Grange, and A. Pozniak. 1993. Old plague, new plague, and a treatment for both? AIDS 7:1275-1277.
23. Stanford, J. L., and C. A. Stanford. 1994. Immunotherapy of tuberculosis with Mycobacterium vaccac NCTC 11659. Immunobiolog 191:555-563
24. Stanford, J. L., C. A. Stanford, G. A. W. Rook, and J. M. Grange. 1994. Immunotherapy for tuberculosis. Clin. Immunother. 1:430-140.
25. Watson, J., T. Sato, D. Chuk, R. L. Prestidge, K. Erb, G. S. Le Gros, and P. L. J. Tan. 1995. Role of eytokines in immune responses to myeobacterial antigens, p. 86-91. In F. Griffin and G. de Lisle (ed.). Tuberculosis in wildlife and domestic animals. University of Otago Press. Dunedin. New Zealand.
26. Zhang, M,. Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and B. F. Barnes. 1995. T-eell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234.